 Bruce Lanser
Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Food Hypersensitivity | 15 | 2025 | 182 | 4.870 |
Why?
| | Allergens | 19 | 2025 | 400 | 2.820 |
Why?
| | Desensitization, Immunologic | 15 | 2025 | 95 | 2.750 |
Why?
| | Peanut Hypersensitivity | 9 | 2025 | 147 | 1.490 |
Why?
| | Omalizumab | 6 | 2025 | 40 | 1.130 |
Why?
| | Anaphylaxis | 5 | 2022 | 107 | 1.050 |
Why?
| | Arachis | 7 | 2025 | 112 | 0.890 |
Why?
| | Immunotherapy | 2 | 2020 | 634 | 0.800 |
Why?
| | Epinephrine | 3 | 2022 | 145 | 0.800 |
Why?
| | Sesamum | 1 | 2023 | 6 | 0.790 |
Why?
| | Anti-Allergic Agents | 4 | 2025 | 41 | 0.770 |
Why?
| | Hypersensitivity | 2 | 2023 | 254 | 0.770 |
Why?
| | Dermatitis, Atopic | 2 | 2021 | 331 | 0.570 |
Why?
| | Milk | 2 | 2023 | 123 | 0.570 |
Why?
| | Pyroglyphidae | 1 | 2018 | 19 | 0.560 |
Why?
| | Humidity | 1 | 2018 | 46 | 0.560 |
Why?
| | Ovum | 1 | 2017 | 31 | 0.550 |
Why?
| | Rhinitis, Allergic | 1 | 2018 | 42 | 0.540 |
Why?
| | Shock | 1 | 2018 | 101 | 0.510 |
Why?
| | Fungi | 1 | 2018 | 150 | 0.500 |
Why?
| | Child Care | 1 | 2016 | 33 | 0.490 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2018 | 386 | 0.470 |
Why?
| | Eosinophils | 1 | 2017 | 322 | 0.450 |
Why?
| | Food | 3 | 2023 | 163 | 0.440 |
Why?
| | Teaching | 1 | 2016 | 233 | 0.410 |
Why?
| | Skin | 1 | 2018 | 754 | 0.410 |
Why?
| | Eosinophilic Esophagitis | 1 | 2017 | 325 | 0.400 |
Why?
| | Child | 18 | 2025 | 21921 | 0.360 |
Why?
| | Child, Preschool | 11 | 2025 | 11158 | 0.320 |
Why?
| | Diet | 2 | 2023 | 1269 | 0.300 |
Why?
| | Caregivers | 1 | 2016 | 904 | 0.280 |
Why?
| | Global Burden of Disease | 2 | 2025 | 24 | 0.270 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1374 | 0.270 |
Why?
| | Biological Products | 2 | 2020 | 231 | 0.250 |
Why?
| | Asthma | 1 | 2018 | 1888 | 0.230 |
Why?
| | Humans | 27 | 2025 | 138651 | 0.230 |
Why?
| | Milk Hypersensitivity | 1 | 2023 | 19 | 0.200 |
Why?
| | Egg Hypersensitivity | 1 | 2023 | 32 | 0.200 |
Why?
| | Cost of Illness | 1 | 2025 | 309 | 0.190 |
Why?
| | Global Health | 1 | 2025 | 383 | 0.180 |
Why?
| | Food Assistance | 1 | 2021 | 30 | 0.180 |
Why?
| | Skin Tests | 2 | 2020 | 97 | 0.180 |
Why?
| | Cholesterol Side-Chain Cleavage Enzyme | 1 | 2020 | 9 | 0.170 |
Why?
| | Enterocolitis | 1 | 2020 | 17 | 0.160 |
Why?
| | Immunoglobulin E | 4 | 2024 | 331 | 0.160 |
Why?
| | Interleukin-13 | 1 | 2020 | 148 | 0.150 |
Why?
| | Transdermal Patch | 1 | 2019 | 15 | 0.150 |
Why?
| | Th2 Cells | 1 | 2020 | 177 | 0.150 |
Why?
| | Adolescent | 8 | 2025 | 21564 | 0.150 |
Why?
| | Curriculum | 2 | 2016 | 1009 | 0.150 |
Why?
| | Humidifiers | 1 | 2018 | 1 | 0.140 |
Why?
| | Prevalence | 1 | 2025 | 2727 | 0.140 |
Why?
| | Allergists | 1 | 2018 | 11 | 0.140 |
Why?
| | Plant Proteins | 1 | 2018 | 108 | 0.140 |
Why?
| | Administration, Oral | 4 | 2021 | 788 | 0.140 |
Why?
| | Administration, Cutaneous | 3 | 2025 | 128 | 0.130 |
Why?
| | Schools | 1 | 2020 | 447 | 0.130 |
Why?
| | Double-Blind Method | 4 | 2025 | 1949 | 0.120 |
Why?
| | Immune Tolerance | 1 | 2018 | 366 | 0.120 |
Why?
| | Infant | 5 | 2025 | 9574 | 0.120 |
Why?
| | Probiotics | 1 | 2015 | 56 | 0.110 |
Why?
| | Hot Temperature | 1 | 2017 | 393 | 0.110 |
Why?
| | Animals | 5 | 2023 | 37217 | 0.110 |
Why?
| | Needs Assessment | 1 | 2016 | 379 | 0.100 |
Why?
| | Leadership | 1 | 2015 | 390 | 0.090 |
Why?
| | Patient Education as Topic | 1 | 2015 | 766 | 0.080 |
Why?
| | Disease Models, Animal | 1 | 2018 | 4315 | 0.070 |
Why?
| | Colorado | 1 | 2018 | 4555 | 0.070 |
Why?
| | Treatment Outcome | 4 | 2025 | 10923 | 0.060 |
Why?
| | Male | 7 | 2025 | 68260 | 0.060 |
Why?
| | Young Adult | 4 | 2025 | 13305 | 0.060 |
Why?
| | Female | 7 | 2025 | 73763 | 0.060 |
Why?
| | Internship and Residency | 1 | 2015 | 1187 | 0.060 |
Why?
| | Nuts | 1 | 2022 | 12 | 0.050 |
Why?
| | Cooking | 1 | 2023 | 66 | 0.050 |
Why?
| | Adult | 5 | 2025 | 38201 | 0.050 |
Why?
| | Mice | 1 | 2018 | 17814 | 0.040 |
Why?
| | Food Supply | 1 | 2021 | 86 | 0.040 |
Why?
| | Mucous Membrane | 1 | 2021 | 125 | 0.040 |
Why?
| | Aminoglutethimide | 1 | 2020 | 5 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2018 | 15909 | 0.040 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 116 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2021 | 243 | 0.040 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2018 | 85 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2020 | 810 | 0.040 |
Why?
| | Confidence Intervals | 1 | 2019 | 328 | 0.040 |
Why?
| | Transfection | 1 | 2020 | 941 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2020 | 1235 | 0.030 |
Why?
| | Gastrointestinal Diseases | 1 | 2018 | 206 | 0.030 |
Why?
| | Eating | 1 | 2019 | 392 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2020 | 1148 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2020 | 1034 | 0.030 |
Why?
| | Cell Line | 1 | 2020 | 2876 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1641 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2020 | 2815 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 3256 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5112 | 0.020 |
Why?
| | Middle Aged | 2 | 2024 | 33604 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4092 | 0.020 |
Why?
| | Signal Transduction | 1 | 2020 | 5086 | 0.020 |
Why?
| | Risk Factors | 1 | 2020 | 10252 | 0.020 |
Why?
| | United States | 1 | 2021 | 14938 | 0.010 |
Why?
|
|
Lanser's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|